SAN ANTONIO—Merck & Co.'s Keytruda and Roche's Tecentriq are battling for immuno-oncology supremacy in an ever-growing range of indications.
News
- SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq ...
- Secret donor powered $2M in yearly S.A., Laredo scholarships - San Antonio Express-News
... 17, a senior at Young Women's Leadership Academy in the San Antonio Independent School District. She hopes to study biomedical engineering at ...
- Op-ed: It's time to look south - San Antonio Business Journal
South San Antonio has reached a moment in time every investor dreams of – where the gains ... San Antonio biotech goes public raising nearly $8M ...
- Every picture tells a story: San Antonio photographer captures Faces of Islam | TPR
“Overwhelmingly, what I heard from them, is that San Antonio in particular is such a welcoming community for Muslims,” Samandari said.
- San Antonio biotech goes public raising nearly $8M - The Business Journals
BioAffinity Technologies Inc. CEO Maria Zannes says the company will keep its headquarters in San Antonio. BioAffinity Technologies.